Summit Investment Advisors, Inc.\KS’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Summit Investment Advisors, Inc.\KS's LLY Position: Q3 2026 in Review
Summit Investment Advisors, Inc.\KS reduced its Eli Lilly (LLY) stake by 0.67% in Q3 2026, selling an estimated $18.9K and leaving 2,387 shares worth $2.76M. The position accounts for 1.25% of the portfolio, ranked #15.
Summit Investment Advisors, Inc.\KS first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.88M in Q2 2026. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Summit Investment Advisors, Inc.\KS held 2,387 shares of Eli Lilly worth $2.76M as of Q3 2026.
- Summit Investment Advisors, Inc.\KS sold 16 Eli Lilly shares in Q3 2026, an estimated $18.9K.
- Eli Lilly made up 1.25% of Summit Investment Advisors, Inc.\KS's portfolio in Q3 2026, its #15 holding.
- Summit Investment Advisors, Inc.\KS first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Summit Investment Advisors, Inc.\KS's Eli Lilly position peaked at $2.88M in Q2 2026.
- 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Summit Investment Advisors, Inc.\KS's 13F filing for Q3 2026, filed 5 Nov 2026.